- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00383253
Methods Study to Characterize Early Indicators of Weight Loss in People
March 20, 2009 updated by: Pfizer
A Randomized, Open-Label, Parallel Group, Fixed Energy Deficit Methodology Trial to Characterize Early Efficacy Biomarkers During Treatment of Obesity in Adult, Obese, Male Subjects.
Methods study to characterize early indicators of weight loss in people.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Australia
-
Adelaide, South Australia, Australia, 5000
- Pfizer Investigational Site
-
North Adelaide, South Australia, Australia, 5006
- Pfizer Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Subjects >=18 years of age with BMI >= 30 and < 40 kg/m2
Exclusion Criteria:
- Females, those with illnesses expected to cause weight loss, those without stable body weight within 3 months of screening.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control
|
Subjects maintained on their baseline caloric intake (caloric restriction = none)
|
Experimental: 10%
|
Subjects maintained on 10% caloric restriction (caloric intake = 90% of baseline)
|
Experimental: 25%
|
Subjects maintained on 25% caloric restriction (caloric intake = 75% of baseline)
|
Experimental: 50%
|
Subjects maintained on 50% caloric restriction (caloric intake = 50% of baseline)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate the effect of varying degrees of controlled, 1-month, caloric restriction on weight loss, and response of known circulating, candidate biomarkers
Time Frame: Throughout trial
|
Throughout trial
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate the time course, magnitude and biomarkers of metabolic compensation as well as assessment of well being (via questionnaires) following varying degrees of controlled, 1-month, caloric restriction
Time Frame: Throughout trial
|
Throughout trial
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2006
Study Completion (Actual)
March 1, 2008
Study Registration Dates
First Submitted
September 29, 2006
First Submitted That Met QC Criteria
October 2, 2006
First Posted (Estimate)
October 3, 2006
Study Record Updates
Last Update Posted (Estimate)
March 23, 2009
Last Update Submitted That Met QC Criteria
March 20, 2009
Last Verified
March 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A9001342
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on caloric restriction - 10%
-
Federal University of Minas GeraisRecruiting
-
Karolinska University HospitalCompleted
-
Centre d'Alt RendimentCompleted
-
Korea UniversityEulji University HospitalCompletedOverweight | Type 2 DiabetesKorea, Republic of
-
University Hospital, MontpellierUnknownType 2 Diabetes | Severe ObesityFrance
-
Federico II UniversityFondazione Italiana Sclerosi MultiplaRecruitingMultiple Sclerosis, Relapsing-Remitting | Caloric RestrictionItaly
-
Wake Forest University Health SciencesActive, not recruiting
-
Pennington Biomedical Research CenterNational Institute on Aging (NIA)Completed
-
Central Hospital, Nancy, FranceRecruitingCrohn's DiseaseFrance
-
Sun Yat-sen UniversityCompletedWeight Loss | Cardiometabolic Risk | Intestinal Microbiome | Immune SystemChina